File Size :Â 40.8 GB
Pathology of the lower anogenital tract, lower urinary tract, prostate, uterus, and cervix has advanced with the identification of relevant genes, better immunohistochemical markers, and the ability to readily detect human papillomavirus (HPV) using RNA in situ hybridization. New entities have recently been recognized, refinements to existing ones are possible, and new treatment, particularly immunotherapy, are available. Expert faculty will discuss newer entities and pitfalls in these areas, while also addressing diagnostic challenges in cytology and newly adopted classification schemes.
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
– Discuss novel recently described human papilloma virus (HPV)-associated and HPV-independent neoplasms of the lower genital tract
– Present a modern viewpoint for grading prostatic carcinoma
– Address pitfalls in diagnosing urothelial neoplasms versus those from adjoining sites, including treatment related pitfalls
– Consider mimickers of common neoplasms of the anogenital and urothelial tracts
– Establish systematic approach to diagnostic challenges in cytology
ProgramÂ
Items Included in the Purchase of this Course
– Male Genital Tract Infernos – Sara E. Wobker MD, MPH
– Lower Gastrointestinal Tract Infernos – Elizabeth Montgomery, MD
– Female Genital Tract Infernos – Andre Pinto, MD
– Cytologic Infernos – Christopher J. VandenBussche, MD
– Male Genital Tract Mirages – Sara E. Wobker MD, MPH
– Lower Gastrointestinal Tract Mirages – Elizabeth Montgomery, MD
– Female Genital Tract Mirages – Andre Pinto, MD
– Cytologic Mirages – Christopher J. VandenBussche, MD
Original release date:Â May 16, 2023
Access to this course expires on:  April 11, 2026
